EGFR and small cell lung carcinoma: Most cases of acquired resistance to EGFR-TKI arise from the emergence of T790M mutation, and morphological transformation to SCLC is rare.1 After the failure of EGFR-TKI, rebiopsy of the tumour is warranted to determine the next treatment strategy.